Two years of treatment with the recombinant grass pollen allergy vaccine BM32 induces a continuously increasing allergen-specific IgG4 response by Julia Eckl-Dorna, Milena Weber, Victoria Stanek, Birgit Linhart, Robin Ristl, Eva E. Waltl, Sergio Villazala-Merino, Andrea Hummel, Margarete Focke-Tejkl, Renate Froeschel, Angela Neubauer, Rainer Henning, Thomas Perkmann, Rudolf Valenta, Verena Niederberger

Get full text